This job has expired

You will need to login before you can apply for a job.

Principal Scientist, Immunology, Infectious Disease

Moderna, Inc.
Cambridge, MA
Start date
Mar 3, 2023

View more

Job Details

The Role:

The Infectious Diseases group at Moderna is seeking a talented, experienced, and motivated Scientist in Immunology to help build an antibody discovery pipeline for novel therapeutics to treat infectious diseases. The candidate must have experience working in antibody discovery, developing platforms for screening, developing strategies for rapid/automated downselect, and characterization. The candidate will develop a high throughput antibody discovery pipeline, using different discovery strategies, to capture, profile, characterize, and explore the therapeutic impact of newly defined monoclonal antibodies. The candidate will also work to explore novel antibody formats to improve potency and to exploit animal models to define canonical and non-canonical mechanisms of action. The candidate will finally be responsible for integrating machine learning and artificial intelligence based strategies in the optimization and design of next generation therapeutics. The candidate will lead a number of parallel discovery campaigns both internally and externally and work with research organizations to evaluate novel therapeutics. The individual will interface with collaborators and present results both internally and externally. The ability to effectively communicate across internal multi-disciplinary teams and with external partners is required. Applicants should be outstanding scientists with experience at several biotech companies, work as a collaborative team member, possess excellent communication skills, have a robust publication track record, and should be excited to work with cutting edge mRNA technology in the advancement of vaccines against unmet infectious and non-infectious disease threats.

Here's What Youll Do:

Develop and explore a number of different novel antibody discovery pipelines both internally and externally

Develop a down selection strategy

Develop new frameworks for the functional evaluation of promising therapeutics across pathogens

Develop a platform strategy for rapid updating of monoclonal antibodies

Develop non-canonical functional strategies to drive pathogen control and clearance

Develop a high-throughput strategy to map epitope specificity and define structural interactions with target antigens

Define new modalities to improve antibody potency via multimerization

Develop and deploy novel animal model screening strategies to test in vivo efficacy

Develop strategies to incorporate artificial intelligence and in silico antibody design to discover and/or improve antibodies

Develop in vitro mRNA antibody characterization strategies

Review literature for relevant monoclonal therapeutic opportunities across pathogens.

Manage multiple experiments, projects, and interactions with supporting functions simultaneously.

Heres What Youll Bring to the Table:

Exceptional PhD with expertise in antibody identification and characterization is required.

A minimum of 5 years of independent research experience in biotech is required.

Experience working across biotech companies.

Strong understanding of antibody format improvement.

Strong understanding of evolving viral pathogens.

Strong level of understanding of antibody discovery platforms.

Solid understanding of anti-microbial assay development

Expertise in antibody assays, flow based assays, and pathogen-restriction assays will be a plus.

Contributions to high impact publications and presentations in the field of infectious disease, immunology or antibody therapeutics is required.

The ability to work in a cross-functional work environment is critical; strong leadership skills and independence skills are expected.

Excellent written, presentation and interpersonal communication skills; ability to influence and collaborate in a team environment.

Candidate will be curious in exploring new path for drug discovery, bold in proposing creative experimental designs and ideas. Will work collaboratively with multifunctional teams and will be relentless in pursuing successful outcomes.

Moderna is pleased to provide you and your family with a comprehensive and innovative suite of benefits, including:

  • Highly competitive and inclusive medical, dental and vision coverage options
  • Flexible Spending Accounts for medical expenses and dependent care expenses
  • Lifestyle Spending Account funds to help you engage in personal enrichment and self-care activities
  • Family care benefits, including subsidized back-up care options and on-demand tutoring
  • Free premium access to fitness, nutrition, and mindfulness classes
  • Exclusive preferred pricing on Peloton fitness equipment
  • Adoption and family-planning benefits
  • Dedicated care coordination support for our LGBTQ+ community
  • Generous paid time off, including:
    Vacation, sick time and holidays
    Volunteer time to participate within your community
    Discretionary year-end shutdown
    Paid sabbatical after 5 years; every 3 years thereafter
  • Generous Paid Leave offerings, including 18 weeks of 100% paid parental leave for all new parents
  • 401k match and Financial Planning tools
  • Moderna-paid Life, LTD and STD insurance coverages, as well as voluntary benefit options
  • Complimentary concierge service including home services research, travel booking, and entertainment requests
  • Free parking or subsidized commuter passes
  • Location-specific perks and extras!

Candidates should be aware that Moderna currently maintains a policy requiring all US-based employees to be fully vaccinated against COVID-19 and receive a booster shot once eligible. Newly hired employees must be vaccinated and boosted prior to their employment start date. Moderna is an equal opportunity employer and will provide a reasonable accommodation to those unable to be vaccinated or receive a booster where it is not an undue hardship to the company to do so as provided under federal, state, and local law.

About Moderna

In over 10 years since its inception, Moderna has transformed from a research-stage company advancing programs in the field of messenger RNA (mRNA), to an enterprise with a diverse clinical portfolio of vaccines and therapeutics across seven modalities, a broad intellectual property portfolio in areas including mRNA and lipid nanoparticle formulation, and an integrated manufacturing plant that allows for rapid clinical and commercial production at scale. Moderna maintains alliances with a broad range of domestic and overseas government and commercial collaborators, which has allowed for the pursuit of both groundbreaking science and rapid scaling of manufacturing. Most recently, Moderna's capabilities have come together to allow the authorized use and approval of one of the earliest and most effective vaccines against the COVID-19 pandemic.

Moderna's mRNA platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, and has allowed the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases and autoimmune diseases. Moderna has been named a top biopharmaceutical employer by Science for the past seven years. To learn more, visit

Moderna is a smoke-free, alcohol-free and drug-free work environment.

Moderna is committed to equal employment opportunity and non-discrimination for all employees and qualified applicants without regard to a persons race, color, gender, age, religion, national origin, ancestry, disability, veteran status, genetic information, sexual orientation or any characteristic protected under applicable law. Moderna will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.




Moderna is advancing messenger RNA (mRNA) science to create a new class of transformative medicines for patients. Moderna’s platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, providing the Company the capability to pursue in parallel a robust pipeline of new development candidates. Moderna is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and cardiovascular diseases, independently and with strategic collaborators.

mRNA is now a turning point in the history of science, medicine, technology, even humankind itself. With this breakthrough discovery, many of the world’s biggest and most challenging medical problems are no longer a question of “how?” but merely a question of “when?”

Come with us as we pursue the uncharted reaches of possibility and make your mark on the future of medicine.


Stock Symbol:


Stock Exchange:



Facebook  Instagram  Twitter


Find Us
200 Technology Square
Cambridge, MA

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert